Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03765138 · ClinicalTrials.gov registry record · Phase 3
Combined Treatment of Prolonged Exposure and Pramipexole for Posttraumatic Stress Disorder and Depression
A Phase 3 study, sponsored by Research Foundation for Mental Hygiene.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT03765138 is a Phase 3 study that was terminated before completion, run by Research Foundation for Mental Hygiene. The registered enrollment target is 1 participants.
The verdict
NCT03765138, a Phase 3 study, was terminated before completion, sponsored by Research Foundation for Mental Hygiene.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
This pilot study aims to test the safety, feasibility, and initial efficacy of combined 10 week treatment of prolonged exposure (PE) and Pramipexole in patients with comorbid posttraumatic stress disorder (PTSD) and depression (MDD). Resting state functional connectivity (rsFC) will be assessed at baseline and en of treatment.
Interventions
- COMBINATION_PRODUCT PE/Pramipexole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2019-08-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03765138
The ClinicalTrials.gov registry entry for NCT03765138 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Foundation for Mental Hygiene, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PE/Pramipexole is the first listed.
NCT03765138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03765138 about?
NCT03765138 is a clinical study titled "Combined Treatment of Prolonged Exposure and Pramipexole for Posttraumatic Stress Disorder and Depression". This pilot study aims to test the safety, feasibility, and initial efficacy of combined 10 week treatment of prolonged exposure (PE) and Pramipexole in patients with comorbid posttraumatic stress disorder (PTSD) and depression (MDD). Resting state functional connectivity (rsFC) will be assessed at b...
What is the current status of trial NCT03765138?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2019-02-19. Estimated completion is 2019-08-26.
What interventions are being tested in trial NCT03765138?
The interventions under investigation include: PE/Pramipexole (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03765138?
This trial is sponsored by Research Foundation for Mental Hygiene, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.